Trial intelligence / Profile preview

Oral vs sublingual captopril for acute high blood pressure

IRCT20220516054869N2Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of captopril in hypertension (HTN) (2 arms), sponsored by Zahedan University of Medical Sciences. Started Sep 2022; status: completed.

02

Drugs

captopril
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on IRCT20220516054869N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220516054869N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call